APVO — Aptevo Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapNeutral

Annual balance sheet for Aptevo Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Cash and Short Term Investments	40	45	22.6	16.9	8.71
Net Total Accounts Receivable
Net Total Receivables	2.37	3.66	2.5	0	—
Prepaid Expenses
Total Other Current Assets
Total Current Assets	47.3	52.6	27.4	19.1	10.7
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	5.54	3.96	6.76	5.78	4.93
Other Long Term Assets
Total Assets	53.5	56.6	34.2	24.8	15.6
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	14.5	34.8	8.71	7.22	6.21
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	37	55.4	16.2	12.6	10.8
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	16.6	1.22	18	12.2	4.75
Total Liabilities & Shareholders' Equity	53.5	56.6	34.2	24.8	15.6
Total Common Shares Outstanding